Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
247,366
-
Shares change
-
-17,390
-
Total reported value, excl. options
-
$412,419
-
Value change
-
-$29,039
-
Number of buys
-
4
-
Number of sells
-
5
-
Price
-
$1.67
Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q2 2025
As of 30 Jun 2025 BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 247,366 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, WEALTH ALLIANCE, LLC, StoneX Group Inc., MORGAN STANLEY, VANGUARD GROUP INC, STATE STREET CORP, Virtu Financial LLC, Newman Dignan & Sheerar, Inc., RAYMOND JAMES FINANCIAL INC, and OSAIC HOLDINGS, INC..
This table shows 15 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.